The Collaborative Role of Medication Management in a Patient-Centered Medical Home (PCMH)

Target Audience

This activity has been designed to meet the educational needs of physicians, pharmacists, registered nurses, and care providers affiliated with a patient-centered medical home.

Statement of Need/Program Overview

A new strategy that has emerged to focus on care delivery, payment reform, and the use of health information technology that is gaining momentum is the patient-centered medical home (PCMH). The PCMH is largely based on principles developed by four primary care professional societies: the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Physicians, and the American Osteopathic Association. The PCMH model is expected to improve the quality of health care by avoiding inconsistent treatments and medications, increasing the amount of preventive care, and improving patient adherence. Health care professionals in a PCMH setting need instruction and tools to assist with identifying the right patients, coordinating the right care, and monitoring the right follow up, to ensure successful short and long term medication outcomes for patients with chronic illnesses.

Educational Objectives
After completing this activity, the participant should be better able to:

 

Distinguished Faculty
Bryan Bray, PharmD, CPP
Chief Operating Officer
Medication Management, LLC
Vice President,
Piedmont Pharmaceutical Care Network

Click here for biography
Terry A. McInnis, MD, MPH
President
Blue Thorn Inc.
Consultant Vice President
Medication Management Systems

Click here for biography
Vanita K. Pindolia, PharmD, BCPS
Vice President, Ambulatory Clinical Pharmacy Services
Director, Managed Care Residency Program
Henry Ford Health System

Click here for biography

Activity Agenda
Pre-activity Learning Assessment

The Collaborative Role of Medication Management in a PCMH
Terry A. McInnis, MD, MPH

Comprehensive Medication Management Services to Improve Patient Outcomes in a PCMH
Bryan Bray, PharmD, CPP

PCMH Best Practices
Vanita K. Pindolia, PharmD, BCPS

Post-activity Learning Assessment

Physician Continuing Medical Education

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM), Impact Education, LLC, and the Patient-Centered Primary Care Collaborative (PCPCC). PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.7 contact hours (0.17 CEUs) of the Accreditation Council for Pharmacy Education.

Activity Type

Knowledge-based.

Nursing Continuing Education

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

This educational activity for 1.7 contact hours is provided by Postgraduate Institute for Medicine.

Fee Information

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter

Reported Financial Relationship

Bryan Bray

Fees for Non-CME/CE Services Received Directly From a Commercial Interest or their Agents (eg, speakers’ bureaus): Sanofi-Aventis and Pfizer Inc.

Terry A. McInnis

Salary: Glaxo SmithKline (former Medical Director, Health Policy and Advocacy)
Ownership Interest: Consultant Medication Management Systems, MN

Vanita K. Pindolia

Salary: Henry Ford Health System

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner

Reported Financial Relationship

Steve Casebeer, MBA
(Impact Education, LLC)

No financial interest/relationships relating to the topic of this activity

The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Patricia Staples, MSN, NP-C, CCRN, Trace Hutchison, PharmD, Julia Kimball, RN, BSN, Samantha Mattiucci, PharmD and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period November 19, 2010 through May 19, 2012, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the online post-test, with a passing score of 70% or better; 4) complete the online evaluation form.

Upon successful completion of post-test and evaluation, you will have access to an immediate online certificate.

Media

Internet

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Impact Education, LLC, the Patient-Centered Primary Care Collaborative (PCPCC), Abbott Laboratories, and Boehringer Ingelheim Pharmaceuticals, Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Impact Education, LLC, the Patient-Centered Primary Care Collaborative (PCPCC), Abbott Laboratories, and Boehringer Ingelheim Pharmaceuticals, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.